US2023293527A1PendingUtilityA1
Treatment of inflammatory disorders
Est. expiryOct 10, 2037(~11.2 yrs left)· nominal 20-yr term from priority
A61K 31/517A61K 31/47A61K 31/423A61K 31/428A61K 31/136A61P 27/04A61P 1/00A61P 9/10A61P 9/12A61P 13/12A61P 25/08A61P 25/28A61P 15/08A61P 27/14A61P 29/00
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides compounds and methods of use thereof for treating inflammatory diseases or disorders.
Claims
exact text as granted — not AI-modifiedWe claim:
1 - 13 . (canceled)
14 . A method of treating a disease, disorder, or condition, comprising administering to a subject in need thereof an effective amount of the following compound:
or a pharmaceutically acceptable salt thereof,
wherein the disease, disorder, or condition is psoriasis or psoriatic arthritis.
15 . The method according to claim 14 , wherein the disease, disorder, or condition is psoriasis.
16 . The method according to claim 14 , wherein the disease, disorder, or condition is psoriatic arthritis.
17 . The method according to claim 14 , wherein the compound or pharmaceutically acceptable salt thereof is administered as a free base.
18 . The method according to claim 14 , wherein the compound or pharmaceutically acceptable salt thereof is administered systemically to the subject.
19 . The method according to claim 14 , wherein the compound or pharmaceutically acceptable salt thereof is administered orally to the subject.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.